Cargando…

Formulation and Evaluation of a Novel Matrix-Type Orally Disintegrating Ibuprofen Tablet

Orally disintegrating tablets (ODTs) are capable of turning quickly into a liquid dosage form in contact with the saliva, thus possessing the advantages of both the solid dosage forms particularly stability and liquid dosage forms specially ease of swallowing and pre-gastric absorption of drug. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Tayebi, Hoda, Mortazavi, Seyed Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813047/
https://www.ncbi.nlm.nih.gov/pubmed/24250378
_version_ 1782289036824543232
author Tayebi, Hoda
Mortazavi, Seyed Alireza
author_facet Tayebi, Hoda
Mortazavi, Seyed Alireza
author_sort Tayebi, Hoda
collection PubMed
description Orally disintegrating tablets (ODTs) are capable of turning quickly into a liquid dosage form in contact with the saliva, thus possessing the advantages of both the solid dosage forms particularly stability and liquid dosage forms specially ease of swallowing and pre-gastric absorption of drug. The aim of this study was to prepare a novel matrix-type buccal fast disintegrating ibuprofen tablet formulation using special polymers, water soluble excipients, super-disintegrants and quickly soluble granules. For this purpose different tablet formulations of ibuprofen were prepared. The amount of ibuprofen in each formulation was 100 mg. Eight groups of formulation were prepared (A-H series), accounting for a total number of 45 formulations. Formulations prepared were examined in terms of different physicochemical tests including powder/granule flowability, appearance, thickness, uniformity of weight, hardness, friability and disintegration time. Results of formulation F(22a) (in series F), was found to be acceptable, making it the chosen formulation for further studies. Then, by adding various flavorants and sweeteners to this formulation, complementary series of formulations, named G and H, were prepared. Following the comparison of their taste with each other through asking 10 volunteers, the most suitable formulation regarding the taste, being formulation F(22s), was chosen as the ultimate formulation. This formulation had PVP, ibuprofen and croscarmellose as the intra-granular components and xylitol and saccharin as the extra-granular ingredients. Formulation F(22s) was found to be acceptable in terms of physicochemical tests conducted, showing quick disintegration within the buccal cavity, appropriate hardness and rather low friability. Hence formulation F(22s) was selected as the final formulation.
format Online
Article
Text
id pubmed-3813047
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-38130472013-11-18 Formulation and Evaluation of a Novel Matrix-Type Orally Disintegrating Ibuprofen Tablet Tayebi, Hoda Mortazavi, Seyed Alireza Iran J Pharm Res Original Article Orally disintegrating tablets (ODTs) are capable of turning quickly into a liquid dosage form in contact with the saliva, thus possessing the advantages of both the solid dosage forms particularly stability and liquid dosage forms specially ease of swallowing and pre-gastric absorption of drug. The aim of this study was to prepare a novel matrix-type buccal fast disintegrating ibuprofen tablet formulation using special polymers, water soluble excipients, super-disintegrants and quickly soluble granules. For this purpose different tablet formulations of ibuprofen were prepared. The amount of ibuprofen in each formulation was 100 mg. Eight groups of formulation were prepared (A-H series), accounting for a total number of 45 formulations. Formulations prepared were examined in terms of different physicochemical tests including powder/granule flowability, appearance, thickness, uniformity of weight, hardness, friability and disintegration time. Results of formulation F(22a) (in series F), was found to be acceptable, making it the chosen formulation for further studies. Then, by adding various flavorants and sweeteners to this formulation, complementary series of formulations, named G and H, were prepared. Following the comparison of their taste with each other through asking 10 volunteers, the most suitable formulation regarding the taste, being formulation F(22s), was chosen as the ultimate formulation. This formulation had PVP, ibuprofen and croscarmellose as the intra-granular components and xylitol and saccharin as the extra-granular ingredients. Formulation F(22s) was found to be acceptable in terms of physicochemical tests conducted, showing quick disintegration within the buccal cavity, appropriate hardness and rather low friability. Hence formulation F(22s) was selected as the final formulation. Shaheed Beheshti University of Medical Sciences 2011 /pmc/articles/PMC3813047/ /pubmed/24250378 Text en © 2011 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Tayebi, Hoda
Mortazavi, Seyed Alireza
Formulation and Evaluation of a Novel Matrix-Type Orally Disintegrating Ibuprofen Tablet
title Formulation and Evaluation of a Novel Matrix-Type Orally Disintegrating Ibuprofen Tablet
title_full Formulation and Evaluation of a Novel Matrix-Type Orally Disintegrating Ibuprofen Tablet
title_fullStr Formulation and Evaluation of a Novel Matrix-Type Orally Disintegrating Ibuprofen Tablet
title_full_unstemmed Formulation and Evaluation of a Novel Matrix-Type Orally Disintegrating Ibuprofen Tablet
title_short Formulation and Evaluation of a Novel Matrix-Type Orally Disintegrating Ibuprofen Tablet
title_sort formulation and evaluation of a novel matrix-type orally disintegrating ibuprofen tablet
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813047/
https://www.ncbi.nlm.nih.gov/pubmed/24250378
work_keys_str_mv AT tayebihoda formulationandevaluationofanovelmatrixtypeorallydisintegratingibuprofentablet
AT mortazaviseyedalireza formulationandevaluationofanovelmatrixtypeorallydisintegratingibuprofentablet